全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

为什么选择我们？ >>
- 开源期刊
- 同行审议
- 快速出刊
- 终身存储
- 免费检索
- 免费推广
- 更多...
- 搜索引擎

Generics and Biosimilars Initiative Journal

ISSN Print: 2033-6403

ISSN Online:

主页: http://www.gabi-journal.net

分享:




Go

Biologicals and biosimilars: a review of the science and its implications

Professor Paul J Declerck, PhD

The potential of generics policies: more room for exploitation–PPRI Conference Report

Sabine Vogler, PhD

Austria could save Euros 256 million by using more generics

Christoph Baumg？rtel, MD

Rythym

GaBI Journal Editor

Tighter EU rules on pharmacovigilance for biologicals

GaBI Journal Editor

Statin generics: no differences in efficacy after switching

Christoph Baumg？rtel, MD

The potential for doctors to contribute to biosimilar guidelines

GaBI Journal Editor

A patient-centred paradigm for the biosimilars market

James N Class, PhD,Lauren Langis, JD

Generics substitution in primary care: summary of the Dutch community pharmacies guidelines

Leonora Grandia, PharmD,Professor Arnold G Vulto, PharmD, PhD

Saving money in the European healthcare systems with biosimilars

Robert Haustein,Christoph de Millas,Ariane H？er, MD,Professor Bertram H？ussler, MD

Pharmacovigilance of biosimilars: challenges and possible solutions

Thijs J Giezen, PharmD, PhD,Sabine MJM Straus, MD, PhD

A review of generic medicine pricing in Europe

Professor Steven Simoens, MSc, PhD

Generic and therapeutic orphans

Professor Philip Walson, MD

What lessons can be learned from the launch of generic clopidogrel?

Christoph Baumg？rtel, MD,Brian Godman, BSc, PhD,Rickard E Malmstrom, MD, PhD,Morten Andersen, MD, PhD

Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach

Brian Godman, BSc, PhD,Mohammed Abuelkhair, PharmD,Agnes Vitry, PharmD, PhD,Shajahan Abdu, MD

The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overview

Sabine Vogler, PhD

Reference pricing systems in Europe: characteristics and consequences

Pieter Dylst, PharmD,Professor Steven Simoens, MSc, PhD,Professor Arnold G Vulto, PharmD, PhD

Terminology for biosimilars–a confusing minefield

Robin Thorpe, PhD, FRCPath,Meenu Wadhwa, PhD

A bioethicist’s view of the use of biosimilars

Carlo Petrini, PhD

Promoting access to biosimilars: a public private partnership model for biosimilar development in underserved populations

Timothy Ken Mackey, MAS,Professor Bryan A Liang, MD, JD, PhD

Health professionals in the risk communication process on counterfeit medicines

Luc Besan？on

The MEDICRIME Convention: criminalising the falsification of medicines and similar crimes

Susanne Keitel, MD

A review of patient perspectives on generics substitution: what are the challenges for optimal drug use

Helle H？konsen, MScPharm, PhD,Else-Lydia Toverud, MScPharm, PhD

Generic clopidogrel–the medicines agency’s perspective

Christoph Baumg？rtel, MD

What to look forward to in GaBI Journal, 2012, issue 2

Professor Philip Walson, MD

How matrix models can support generic medicine prescribing

Robert Janknegt, PharmD, PhD

Readers' Comments

GaBI Journal Editor

A clinician’s view of the ethics of the use of biosimilars

Dr Kalle Hoppu

Myths, questions, facts about generic drugs in the EU

Christoph Baumg？rtel, MD

Generics policies–a globally-relevant implementation challenge

Andy Gray, MSc(Pharm), FPS

Innovator companies should focus on innovations

Professor Theodor Dingermann, PhD

Reference price systems: stakeholder dialogue and involvement

Sabine Vogler, PhD

European payer initiatives to reduce prescribing costs through use of generics

Brian Godman, BSc, PhD,Bjorn Wettermark, MSc, PhD,Iain Bishop, BSc,Thomas Burkhardt, MSc

Latest features in GaBI Journal, 2012, issue 3-4

Professor Philip Walson, MD

Equal protection under the law: Children and the Best Pharmaceuticals for Children Act

Professor Daniel Kelly Benjamin Jr, MD, MPH, PhD,Professor Gregory L Kearns, PharmD, PhD

Abstracted Scientific Content

GaBI Journal Editor

Introduction to the GaBI Journal

Professor Philip Walson, MD

Generic medicine pricing: on track in Europe?

Associate Professor Marc A Koopmanschap, PhD

ICH Q11: development and manufacture of drug substances–chemical and biotechnological/biological entities

Keith McDonald, MSc, MRPharmS,Kowid Ho, PhD

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705